Literature DB >> 3401133

Cotton-wool spots in acquired immunodeficiency syndrome compared with diabetes mellitus, systemic hypertension, and central retinal vein occlusion.

A M Mansour1, L M Jampol, S Logani, J Read, D Henderly.   

Abstract

The cotton-wool spot is a common fundus finding in patients with many ocular and systemic diseases. We investigated the characteristics of cotton-wool spots in patients with four major diseases, ie, acquired immunodeficiency syndrome, diabetes mellitus, systemic hypertension, and central retinal vein occlusion, to see if any differences were detected in their number, size, or location. A composite of all the cotton-wool spots for each of these four categories was obtained by computed reconstruction to analyze variations in their distribution and size. The cotton-wool spots had a predilection for the temporal quadrants in the four categories and were smaller in patients with acquired immunodeficiency syndrome than the other groups. Patients with ischemic central retinal vein occlusion had more cotton-wool spots than the other groups. No other definite differences were detected. Cotton-wool spots than the other groups. No other definite differences were detected. Cotton-wool spots seem to be a common pathway following various insults to the retina, most probably of a vaso-occlusive origin.

Entities:  

Mesh:

Year:  1988        PMID: 3401133     DOI: 10.1001/archopht.1988.01060140230030

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  11 in total

1.  Evidence for cytomegalovirus and human immunodeficiency virus infection of the retina in AIDS.

Authors:  A Schmitt-Gräff; E Neuen-Jacob; B Rettig; R Sundmacher
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 2.  Why cotton wool spots should not be regarded as retinal nerve fibre layer infarcts.

Authors:  D McLeod
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

3.  Objective analysis of retinal damage in HIV-positive patients in the HAART era using OCT.

Authors:  Igor Kozak; Dirk-Uwe Bartsch; Lingyun Cheng; Brian R Kosobucki; William R Freeman
Journal:  Am J Ophthalmol       Date:  2005-02       Impact factor: 5.258

4.  Human immunodeficiency virus-related retinal microangiopathy and systemic cytomegalovirus disease association.

Authors:  Yuko Iwasaki; Narumichi Yamamoto; Tatsushi Kawaguchi; Noriko Ozaki; Makoto Tomita; Atsushi Ajisawa; Manabu Mochizuki; Kimio Murakami
Journal:  Jpn J Ophthalmol       Date:  2013-05-23       Impact factor: 2.447

5.  Imaging of long-term retinal damage after resolved cotton wool spots.

Authors:  Maria Laura Gomez; Francesca Mojana; Dirk-Uwe Bartsch; William R Freeman
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079

6.  Cotton-wool spots and AIDS related complex.

Authors:  A Brezin; B Girard; M Rosenheim; P Marcel; M Gentilini; P Le Hoang
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

7.  Isolated cotton-wool spots of unknown etiology: management and sequential spectral domain optical coherence tomography documentation.

Authors:  Antonis Ioannides; Nikolaos D Georgakarakos; Ibrahim Elaroud; Petros Andreou
Journal:  Clin Ophthalmol       Date:  2011-10-04

8.  Single cotton wool spot as a late manifestation of head trauma.

Authors:  Mohsen Gohari; Ali Reza Soleimani; Masoud Reza Manaviat; Ahmad Shojaei
Journal:  J Ophthalmic Vis Res       Date:  2014-04

9.  Histopathological assessments reveal retinal vascular changes, inflammation and gliosis in patients with lethal COVID-19.

Authors:  Vijay K Jidigam; Rupesh Singh; Julia C Batoki; Caroline Milliner; Onkar B Sawant; Vera L Bonilha; Sujata Rao
Journal:  medRxiv       Date:  2021-02-28

10.  Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia Assessed by Optical Coherence Tomography Angiography.

Authors:  Jorge González-Zamora; Valentina Bilbao-Malavé; Elsa Gándara; Anna Casablanca-Piñera; Claudia Boquera-Ventosa; Manuel F Landecho; Javier Zarranz-Ventura; Alfredo García-Layana
Journal:  Biomedicines       Date:  2021-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.